Vaccination Guide for
Immunosuppressed Patients with IBD

Testing, Logistics, and Monitoring

Edit Content

PRE-TESTING AND VACCINATION

For more detailed information on vaccinations, please see the CANIBD Vaccination Guide

Chest X-ray.
TB skin test
Blood work (baseline CBC, renal and liver function, HBV)

Ensure all immunizations are current.
Wait at least four weeks to start following administration of live vaccination.
Pneumococcal vaccination recommended for adult patients.
Recommend vaccinations: HAV, HBV, HPV, and Tdap
Refer to CANIBD Vaccination Guidelines for further information.10

Use with caution in patients with chronic or recurrent infection.

METHOD OF ADMINISTRATION

IV Infusion

LOCATION

Infusion centre

DOSING

Weight-based dosing. Standard dose is 5 mg/kg.
Induction:  wk 0, wk 2, wk 6,  then maintenance every 8 wks*

Pediatric Dosing:

(≥ 9 years of age) with moderately to severely active Crohn’s disease:

5 mg/kg given as an induction regimen at 0, 2 and 6 weeks followed by a maintenance regimen of 5 mg/kg every 8 weeks.

The safety and efficacy of Remicade® has not been established in pediatric patients with Crohn’s disease <9 years of age.

TIME REQUIRED

3-4 hrs

Those who do not experience a reaction can be infused <2 hrs

ROUTINE MONITORING

Annual cervical cancer screening – pap test
Annual skin exam – skin malignancies
Influenza vaccine recommended
May consider therapeutic drug monitoring (TDM) if available
Screening for osteoporosis with bone mineral density testing periodically after diagnosis

           
Edit Content

PRE-TESTING AND VACCINATION

For more detailed information on vaccinations, please see the CANIBD Vaccination Guide

Chest X-ray
TB skin test
Blood work (baseline CBC, renal and liver function, HBV)

Ensure all immunizations are current.
Wait at least four weeks to start following administration of live vaccination.
Pneumococcal vaccination recommended for adult patients.
Recommend vaccinations: HAV, HBV, HPV, and Tdap
Refer to CANIBD Vaccination Guidelines for further information.10

Use with caution in patients with chronic or recurrent infection.

METHOD OF ADMINISTRATION

SC injection

LOCATION

Home
Infusion centre is also available

DOSING

Induction:
160 mg, 80 mg,
40 mg, wk 0, wk 2, wk 4,

then maintenance
40 mg every 2 wks*

Pediatric Dosing:
13 to 17 years of age

≥ 40 kg: 160 mg at Week 0, 80 mg at Week 2. Maintenance dose regimen is 20 mg every other week beginning at Week 4.

For pediatric patients who experience a disease flare or non-response, dose escalation to 40 mg every other week may be considered

TIME REQUIRED

<15 min

ROUTINE MONITORING

Annual cervical cancer screening – pap test
Annual skin exam – skin malignancies
Influenza vaccine recommended
May consider therapeutic drug monitoring (TDM) if available
Screening for osteoporosis with bone mineral density testing periodically after diagnosis

           
Edit Content

PRE-TESTING AND VACCINATION

For more detailed information on vaccinations, please see the CANIBD Vaccination Guide

Chest X-ray
TB skin test
Blood work (baseline CBC, renal and liver function, HBV)

Ensure all immunizations are current.
Wait at least four weeks to start following administration of live vaccination.
Pneumococcal vaccination recommended for adult patients.
Recommend vaccinations: HAV, HBV, HPV, and Tdap
Refer to CANIBD Vaccination Guidelines for further information.10

Use with caution in patients with chronic or recurrent infection.

METHOD OF ADMINISTRATION

IV infusion x 1 then SC injection

LOCATION

Infusion centre
Home

DOSING

Induction:
300 mg IV x 1 infusion,

then maintenance 90 mg SC every 8 wks*

TIME REQUIRED

1–2 hrs for initial IV infusion
SC injection <15 min

ROUTINE MONITORING

Annual cervical cancer screening – pap test
Annual skin exam – skin malignancies
Influenza vaccine recommended
May consider therapeutic drug monitoring (TDM) if available
Screening for osteoporosis with bone mineral density testing periodically after diagnosis

           
Edit Content

PRE-TESTING AND VACCINATION

For more detailed information on vaccinations, please see the CANIBD Vaccination Guide

TB screening should be considered.

METHOD OF ADMINISTRATION

IV infusion and SC injection

LOCATION

Infusion centre

DOSING

Induction: 300 mg IV wk 0, wk 2, wk 6, then maintenance 300 mg every 8 wks OR following at least 2 IV infusions, 108 mg SC every 2 wks

TIME REQUIRED

1–2 hrs 

ROUTINE MONITORING

Patients should be monitored for any new onset or worsening of neurological signs and symptoms

Liver enzymes – transaminases and bilirubin.

           
Edit Content

PRE-TESTING AND VACCINATION

For more detailed information on vaccinations, please see the CANIBD Vaccination Guide
TB skin test
Blood work (baseline CBC, renal and liver function, HBV)

Ensure all immunizations are current.
Wait at least four weeks to start following administration of live vaccination.
Pneumococcal vaccination recommended for adult patients.
Recommend vaccinations HAV, HBV, HPV, and Tdap.
Refer to CANIBD Vaccination Guidelines for further information.10

Use with caution in patients with chronic or recurrent infection.

Liver tests as per routine patient management prior to initiating therapy.

METHOD OF ADMINISTRATION

IV infusion x 1 then on-body (SC) injector (OBI) with pre-filled cartridge

LOCATION

Infusion centre
Home

DOSING

Induction:
600 mg IV at wk 0, wk 4 and wk 8,

then 360 mg subcutaneous (OBI) at wk 12 and every 8 wks thereafter

TIME REQUIRED

Minimum 1 hr infusion

OBI injection <15 min

ROUTINE MONITORING

Annual cervical cancer screening – pap test
Annual skin exam – skin malignancies
Influenza vaccine recommended
Screening for osteoporosis with bone mineral density testing periodically after diagnosis
Liver enzymes as part of your routine blood work.

           
Edit Content

PRE-TESTING AND VACCINATION

For more detailed information on vaccinations, please see the CANIBD Vaccination Guide

TB skin test
Blood work (baseline CBC, liver enzymes, lipids, CK, renal function, Hepatitis B serology)
Shingrix zoster 
Recommend receiving live vaccines prior to starting therapy

METHOD OF ADMINISTRATION

Oral

LOCATION

Home

DOSING

Induction:
45mg once daily for 12 weeks

then maintenance 15mg or 30mg once daily

TIME REQUIRED

5 minutes 

ROUTINE MONITORING

Baseline blood work – CBC

Liver enzymes, lipids, CK, renal function and Hepatitis B serology

Blood work q 3 months

Including CBC, liver enzymes, lipids, CK, and renal function

           

*Dose and frequency adjustments can be made at the discretion of the practitioner.

†Frequency of infusions can be adjusted at the discretion of the practitioner.

TB: Tuberculosis, CBC: complete blood count, ­HBV: hepatitis B virus, HAV: hepatitis A virus, HPV: Human papillomavirus, Tdap: tetanus, diphtheria, and pertussis, IV: intravenous, SC: subcutaneous, wk: week, hrs: hours, min: minutes.